Erythropoietin in chronic renal failure

[41] Eschbach J. W., 1993, Journal of the American Society of Nephrology, V4, P425

[42] THE FUTURE OF RHUEPO [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 : 96 - 109

[43] ESCHBACH JW, 1992, CLIN NEPHROL, V38, pS98

[44] IRON BALANCE IN HEMODIALYSIS PATIENTS [J]. ANNALS OF INTERNAL MEDICINE, 1977, 87 (06) : 710 - 713

[45] RECOMBINANT HUMAN ERYTHROPOIETIN - IMPLICATIONS FOR NEPHROLOGY [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 11 (03) : 203 - 209

[46] CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) : 73 - 78

[47] THE ANEMIA OF CHRONIC RENAL-FAILURE - PATHO-PHYSIOLOGY AND THE EFFECTS OF RECOMBINANT ERYTHROPOIETIN [J]. KIDNEY INTERNATIONAL, 1989, 35 (01) : 134 - 148

[48] DOES TREATMENT WITH ERYTHROPOIETIN CAUSE VASCULAR ACCESS THROMBOSIS - ERYTHROPOIETIN IS NOT A CAUSE OF ACCESS THROMBOSIS [J]. SEMINARS IN DIALYSIS, 1993, 6 (03) : 180 - 184

[49] EVANS RW, 1990, JAMA-J AM MED ASSOC, V263, P825

[50] CARDIOVASCULAR CONSEQUENCES OF CORRECTION OF THE ANEMIA OF RENAL-FAILURE WITH ERYTHROPOIETIN [J]. KIDNEY INTERNATIONAL, 1993, 44 (06) : 1309 - 1315

[41] Eschbach J. W., 1993, Journal of the American Society of Nephrology, V4, P425

[42] THE FUTURE OF RHUEPO [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 : 96 - 109

[43] ESCHBACH JW, 1992, CLIN NEPHROL, V38, pS98

[44] IRON BALANCE IN HEMODIALYSIS PATIENTS [J]. ANNALS OF INTERNAL MEDICINE, 1977, 87 (06) : 710 - 713

[45] RECOMBINANT HUMAN ERYTHROPOIETIN - IMPLICATIONS FOR NEPHROLOGY [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 11 (03) : 203 - 209

[46] CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) : 73 - 78

[47] THE ANEMIA OF CHRONIC RENAL-FAILURE - PATHO-PHYSIOLOGY AND THE EFFECTS OF RECOMBINANT ERYTHROPOIETIN [J]. KIDNEY INTERNATIONAL, 1989, 35 (01) : 134 - 148

[48] DOES TREATMENT WITH ERYTHROPOIETIN CAUSE VASCULAR ACCESS THROMBOSIS - ERYTHROPOIETIN IS NOT A CAUSE OF ACCESS THROMBOSIS [J]. SEMINARS IN DIALYSIS, 1993, 6 (03) : 180 - 184

[49] EVANS RW, 1990, JAMA-J AM MED ASSOC, V263, P825

[50] CARDIOVASCULAR CONSEQUENCES OF CORRECTION OF THE ANEMIA OF RENAL-FAILURE WITH ERYTHROPOIETIN [J]. KIDNEY INTERNATIONAL, 1993, 44 (06) : 1309 - 1315